2021 Annual Business Report

Our Corporate Governance Approach

Our commitment to Corporate Governance underpins the trust that our investors, employees and institutions have placed in us.

Our Corporate Governance Approach

A specialty vaccine company

Valneva has a two-tier corporate governance system consisting of a Management Board (“Directoire”), which is responsible for managing the Company, and a Supervisory Board (“Conseil de Surveillance”), which oversees the Management Board.

Valneva’s Management Board is a highly experienced international team with diverse backgrounds, experience, expertise, and skills. Our Management Board is comprised of five members,
as shown on the picture above from left to right:

Thomas Lingelbach, Chief Executive Officer, President and Chair of the Management Board
Frédéric Jacotot, General Counsel & Corporate Secretary
Juan Carlos Jaramillo, Chief Medical Officer
Peter Bühler, Chief Financial Officer
Franck Grimaud, Chief Business Officer, “Directeur Général”

Read more

 

Valneva’s Supervisory Board, composed of members with diverse experiences in the life sciences industry, participates actively in reviewing the Company’s strategic options and setting direction, together with the Management Board.

Frédéric Grimaud, Chairman
James Sulat, Vice-Chair
Anne-Marie Graffin
Sharon Tetlow
Johanna Willemina Pattenier

Read more